J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...

Whilst the NHS indubitably runs on international talent, however, this does not stop our system from pushing overseas nurses ...

The positive result in OCEANIC-STROKE means that asundexian can potentially now sit alongside prostate cancer therapy Nubeqa ...

In Evaluate’s recently released annual World Preview Report, including updated global pharmaceutical market projections ...

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled that Angelini has fallen short of its standards by ...

Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of ...

Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation ...

Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group of companies ...

A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could ...

At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial ...